An antidote for acute cocaine toxicity

Molecular Pharmaceutics

Volumn 9, Issue 4, 2012, Pages 969-978

  Treweek, Jennifer B ^a   Janda, Kim D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

antidote; cocaine; drug abuse; immunopharmacotherapy; mice; monoclonal antibody; overdose; passive immunization; vaccine

Indexed keywords

ANTIDOTE; COCAINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GNC92H2; MONOCLONAL ANTIBODY GNCGZK; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; BINDING AFFINITY; COCAINE TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CLEARANCE; DRUG OVERDOSE; IMMUNOPHARMACOLOGY; IN VIVO STUDY; INTOXICATION; LD 50; LETHALITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIDOTES; COCAINE; COCAINE-RELATED DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; MICE; OVERDOSE;

EID: 84859325484     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200588v     Document Type: Article

References (37)

1. Carrera, M. R.; Ashley, J. A.; Parsons, L. H.; Wirsching, P.; Koob, G. F.; Janda, K. D. Suppression of psychoactive effects of cocaine by active immunization Nature 1995, 378, 727-730 (Pubitemid 26001945)
2. Martell, B. A.; Orson, F. M.; Poling, J.; Mitchell, E.; Rossen, R. D.; Gardner, T.; Kosten, T. R. Cocaine vaccine for the treament of cocaine dependence: a randomized double-blind placebo-controlled efficacy trial Arch. Gen. Psychiatry 2009, 66, 1116-1123
3. Kantak, K. M.; Collins, S. L.; Lipman, E. G.; Bond, J.; Giovanoni, K.; Fox, B. S. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model Psychopharmacology 2000, 148, 251-262 (Pubitemid 30136732)
4. Tatsis, N.; Ertl, H. C. Adenoviruses as vaccine vectors Mol. Ther. 2004, 10, 616-629 (Pubitemid 39272851)
5. Carrera, M. R. A.; Trigo, J. M.; Wirsching, P.; Roberts, A. J.; Janda, K. D. Evaluation of the anticocaine monoclonal antibody GNC92H2 as an immunotherapy for cocaine overdose Pharmacol., Biochem. Behav. 2005, 81, 709-714 (Pubitemid 41187802)
6. Carrera, M. R.; Ashley, J. A.; Wirsching, P.; Koob, G. F.; Janda, K. D. A second-generation vaccine protects against the psychoactive effects of cocaine Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 1988-1992 (Pubitemid 32165610)
7. Carrera, M. R.; Ashley, J. A.; Zhou, B.; Wirsching, P.; Koob, G. F.; Janda, K. D. Cocaine vaccines: antibody protection against relapse in a rat model Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 6202-6206 (Pubitemid 30367547)
8. Baird, T. J.; Deng, S. X.; Landry, D. W.; Winger, G.; Woods, J. H. Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats J. Pharmacol. Exp. Ther. 2000, 295, 1127-1134
9. Haney, M.; Gunderson, E. W.; Jiang, H.; Collins, E. D.; Foltin, R. W. Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans Biol. Psychiatry 2010, 67, 59-65
10. Kosten, T. R.; Rosen, M.; Bond, J.; Settles, M.; Roberts, J. S. C.; Shields, J.; Jack, L.; Fox, B. Human therapeutic cocaine vaccine: safety and immunogenicity Vaccine 2002, 20, 1196-1204 (Pubitemid 34135957)
11. Martell, B. A.; Mitchell, E.; Poling, J.; Gonsai, K.; Kosten, T. R. Vaccine Pharmacotherapy for the Treatment of Cocaine Dependence Biol. Psychiatry 2005, 58, 158-164 (Pubitemid 41008133)
12. Cerny, E. H.; Cerny, T. Anti-nicotine abuse vaccines in the pipeline: an update Expert Opin. Invest. Drugs 2008, 17, 691-696 (Pubitemid 351843613)
13. McKenzie, S. J.; Halsey, J. F. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response J. Immunol. 1984, 133, 1818-1824 (Pubitemid 14035270)
14. Kinsey, B. M.; Jackson, D. C.; Orson, F. M. Anti-drug vaccines to treat substance abuse Immunol. Cell Biol. 2009, 87, 309-314
15. Carrera, M. R. A.; Meijler, M. M.; Janda, K. D. Cocaine pharmacology and current pharmacotherapies for its abuse Bioorg. Med. Chem. 2004, 12, 5019-5030 (Pubitemid 39200606)
16. Treweek, J. B.; Roberts, A. J.; Janda, K. D. Immunopharmacotherapeutic manifolds and modulation of cocaine overdose Pharmacol., Biochem. Behav. 2011, 98, 474-484
17. Mendez, M. J.; Green, L. L.; Corvalan, J. R. F.; Jia, X.-C.; Yang, X.-D.; Gallo, M. L.; Louie, D. M.; Lee, D. V.; Erickson, K. L.; Luna, J.; Roy, C. M.-N.; Abderrahim, H.; Kirschenbaum, F.; Noguchi, M.; Smith, D. H.; Fukushima, A.; Hales, J. F.; Finer, M. H.; Geoffrey Davis, C.; Zsebo, K. M.; Jakobovits, A. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice Nat. Genet. 1997, 15, 146
18. Green, L. L. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies J. Immunol. Methods 1999, 231, 11-23 (Pubitemid 30394721)
19. Larsen, N. A.; Zhou, B.; Heine, A.; Wirsching, P.; Janda, K. D.; Wilson, I. A. Crystal structure of a cocaine-binding antibody J. Mol. Biol. 2001, 311, 9-15 (Pubitemid 32735311)
20. Steiniger, S. C.; Altobell, L. J., 3rd; Zhou, B.; Janda, K. D. Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen Mol. Immunol. 2007, 44, 2749-2755 (Pubitemid 46240307)
21. Ritz, M. C.; George, F. R. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites J. Pharmacol. Exp. Ther. 1993, 264, 1333-1343 (Pubitemid 23318630)
22. Hearn, W. L.; Rose, S.; Wagner, J.; Ciarleglio, A.; Mash, D. C. Cocaethylene is more potent than cocaine in mediating lethality Pharmacol., Biochem. Behav. 1991, 39, 531-533
23. Sturgeon, R. D.; Fessler, R. G.; Meltzer, H. Y. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats Eur. J. Pharmacol. 1979, 59, 169-179 (Pubitemid 10159509)
24. Treweek, J. B.; Roberts, A. J.; Janda, K. D. Superadditive effects of ethanol and flunitrazepam: implications of using immunopharmacotherapy as a therapeutic Mol. Pharmaceutics 2010, 7, 2056-2068
25. Proksch, J. W.; Gentry, W. B.; Owens, S. M. Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats J. Pharmacol. Exp. Ther. 2000, 292, 831-837 (Pubitemid 30136572)
26. Laurenzana, E. M.; Gunnell, M. G.; Gentry, W. B.; Owens, S. M. Treatment of adverse effects of excessive phencyclidine exposure in rats with a minimal dose of monoclonal antibody J. Pharmacol. Exp. Ther. 2003, 306, 1092-1098 (Pubitemid 37025318)
27. Pitas, G.; Laurenzana, E. M.; Williams, D. K.; Owens, S. M.; Gentry, W. B. Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted Drug Metab. Dispos. 2006, 34, 906-912 (Pubitemid 43763745)
28. An, Z. Therapeutic Monoclonal Antibodies: From Bench to Clinic; John Wiley & Sons: Hoboken, 2011.
29. Pentel, P. R.; Malin, D. H.; Ennifar, S.; Hieda, Y.; Keyler, D. E.; Lake, J. R.; Milstein, J. R.; Basham, L. E.; Coy, R. T.; Moon, J. W.; Naso, R.; Fattom, A. A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats Pharmacol., Biochem. Behav. 2000, 65, 191-198 (Pubitemid 30018012)
30. Bonese, K. F.; Wainer, B. H.; Fitch, F. W.; Rothberg, R. M.; Schuster, C. R. Changes in heroin self-administration by a rhesus monkey after morphine immunisation Nature 1974, 252, 708-710
31. Laurenzana, E. M.; Byrnes-Blake, K. A.; Milesi-Hallé, A.; Gentry, W. B.; Williams, D. K.; Owens, S. M. Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats Drug Metab. Dispos. 2003, 31, 1320-1326 (Pubitemid 37310320)
32. Peterson, E. C.; Laurenzana, E. M.; Atchley, W. T.; Hendrickson, H. P.; Owens, S. M. Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine J. Pharmacol. Exp. Ther. 2008, 325, 124-133 (Pubitemid 351439176)
33. Valentine, J. L.; Mayersohn, M.; Wessinger, W. D.; Arnold, L. W.; Owens, S. M. Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats J. Pharmacol. Exp. Ther. 1996, 278, 709-716
34. Norman, A. B.; Tabet, M. R.; Norman, M. K.; Buesing, W. R.; Pesce, A. J.; Ball, W. J. A chimeric human/murine anticocaine monoclonal antibody inhibits the distribution of cocaine to the brain in mice J. Pharmacol. Exp. Ther. 2007, 320, 145-153 (Pubitemid 46025729)
35. Fox, B. S.; Kantak, K. M.; Edwards, M. A.; Black, K. M.; Bollinger, B. K.; Botka, A. J.; French, T. L.; Thompson, T. L.; Schad, V. C.; Greenstein, J. L.; Gefter, M. L.; Exley, M. A.; Swain, P. A.; Briner, T. J. Efficacy of a therapeutic cocaine vaccine in rodent models Nat. Med. 1996, 2, 1129-1132 (Pubitemid 26338633)
36. Paula, S.; Tabet, M. R.; Keenan, S. M.; Welsh, W. J.; Ball, W. J. J. Three-dimensional structure-activity relationship modeling of cocaine binding to two monoclonal antibodies by comparative molecular field analysis J. Mol. Biol. 2003, 325, 515-530 (Pubitemid 36062680)
37. Paula, S.; Tabet, M. R.; Farr, C. D.; Norman, A. B.; Ball, W. J. J. Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody J. Med. Chem. 2004, 47, 133-142 (Pubitemid 38040497)